A news article has been posted about Dragonfly Biosciences on the AFR. The article was published around , on 4 July 2023 at 5:00am.
Dragonfly Biosciences, the UK-based maker of cannabidiol-based supplements and lotions, has booked its ASX debut in an initial public offering two years in the making, Street Talk can reveal. The cannabis company is set for an Australian listing in August and intends to raise up to $5 million at 20¢ a piece under the ticker DRF,
Read Article| Recent Articles about ASX:DRF | |
|---|---|
| 16-Dec | Excelsior’s valuation a head scratcher; From Hiro to zero
theaustralian.com.au |
| 31-Oct | What countries are supplying the UK with medical marijuana?
businessleader.co.uk |
| 29-Jul | Tim Boreham: Healthy outlook for Aussie biotech newcomers
thechronicle.com.au |
| 29-Jul | Tim Boreham: Healthy outlook for Aussie biotech newcomers
themercury.com.au |
| 29-Jul | Tim Boreham: Healthy outlook for Aussie biotech newcomers
ntnews.com.au |
| 28-Jul | Tim Boreham: Healthy outlook for Aussie biotech newcomers
geelongadvertiser.com.au |
| 28-Jul | Tim Boreham: Healthy outlook for Aussie biotech newcomers
townsvillebulletin.com.au |
| 28-Jul | Tim Boreham: Healthy outlook for Aussie biotech newcomers
weeklytimesnow.com.au |
| 28-Jul | Tim Boreham: Healthy outlook for Aussie biotech newcomers
adelaidenow.com.au |
| 28-Jul | Tim Boreham: Healthy outlook for Aussie biotech newcomers
goldcoastbulletin.com.au |
| Tracked |
Find all articles about Dragonfly Biosciences, including others on the AFR, on the media page.
You must be logged in to post a reply.
